The Patent Finder

I2O Therapeutics, Inc.

Also on record
Records under this name other than the patents I2O Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 11 patents it holds.

Back to I2O Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
17/121,576Implant Placement and Removal Systems
Abandoned
Abandoned May 9, 2024
AbandonedAbandoned May 9, 2024
17/996,126Long Acting Glucagon Receptor Selective Peptides and Methods of Use
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
17/996,131Use of Human Amylin Analog Polypeptides for Providing Superior Glycemic Control to Type 1 Diabetics
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/176,094Ionic Liquid Formulations for Treating Diabetes
Abandoned
Abandoned May 27, 2026
AbandonedAbandoned May 27, 2026
18/319,010Methods Comprising Continuous Administration of a GLP-1 Receptor Agonist and Co-administration of a Drug
Abandoned
Abandoned Jul 27, 2025
AbandonedAbandoned Jul 27, 2025
18/490,341Glucagon-Receptor Selective Polypeptides and Methods of Use Thereof
Abandoned
Abandoned Feb 16, 2026
AbandonedAbandoned Feb 16, 2026
18/501,735Ionic Liquid Formulations for Treating Inflammatory and Autoimmune Diseases
Abandoned
Abandoned Nov 9, 2026
AbandonedAbandoned Nov 9, 2026
18/598,763Implant Placement and Removal Systems
Abandoned
Abandoned Mar 21, 2025
AbandonedAbandoned Mar 21, 2025
18/779,857Long Acting Glucagon Like POLYPEPTIDE-1 (GLP-1) Receptor Agonists and Methods of Use
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/889,043Long Acting Peptide Tyrosine Tyrosine (PYY) Analogs and Methods of Use
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
10 of 15 records shown.
Pro members see all 15.
Pro members: see all 15 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited